Luis E. García-Ríos, Hepato-Pancreato-Biliary Tumors, Sarcomas, and Digestive Tract Service, Oncology Hospital, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, México City, Mexico
Marisol Luna-Castillo, Hepato-Pancreato-Biliary Tumors, Sarcomas, and Digestive Tract Service, Oncology Hospital, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, México City, Mexico
Erick A. Lopez-Herrera, Hepato-Pancreato-Biliary Tumors, Sarcomas, and Digestive Tract Service, Oncology Hospital, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, México City, Mexico
Ma. Guadalupe J. De Anda-González, Pathology Service, Sarcomas, and Digestive Tract, Oncology Hospital, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, México City, Mexico
Rafael Medrano-Guzmán, Hepato-Pancreato-Biliary Tumors, Sarcomas, and Digestive Tract Service, Oncology Hospital, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, México City, Mexico
Background: Gastrointestinal stromal tumors (GIST) require R0 surgical resection as the standard treatment. Robotic surgery emerges as a promising alternative in complex cases, although no published series exist in Latin America. Objectives: The objective of the study was to evaluate robotic surgery in the treatment of GIST and the impact of tumor size and location on surgical outcomes. Materials and methods: Retrospective observational cohort study at the Oncology Hospital, Centro Médico Nacional Siglo XXI, Mexico City. Twenty patients with GIST underwent robotic surgery (da Vinci Xi) between January 2022 and December 2024, with follow-up until March 2025. Results: Mean age 65.2 years (10 men and 10 women). R0 resection was achieved in 100%, conversion rate to open surgery 5%, mean intraoperative blood loss was 101 mL, mean hospital stay 6.3 days, mean tumor size 5.47 cm, and post-operative morbidity 15%. Median follow-up 19 months: disease-free survival 100%. Conclusion: Robotic resection of GIST in technically complex cases was safe and feasible in this first Mexican series.
Keywords: Gastrointestinal stromal tumors. Robotic surgery. Minimally invasive surgery.